136 related articles for article (PubMed ID: 17669286)
1. Personalized medicine: the promise, the reality.
Campos-Outcalt D
J Fam Pract; 2007 Aug; 56(8):621-6. PubMed ID: 17669286
[No Abstract] [Full Text] [Related]
2. Overview of pharmacogenetics in anticoagulation therapy.
Hill CE; Duncan A
Clin Lab Med; 2008 Dec; 28(4):513-24. PubMed ID: 19059059
[TBL] [Abstract][Full Text] [Related]
3. Individual genomes instead of race for personalized medicine.
Ng PC; Zhao Q; Levy S; Strausberg RL; Venter JC
Clin Pharmacol Ther; 2008 Sep; 84(3):306-9. PubMed ID: 18714319
[TBL] [Abstract][Full Text] [Related]
4. The FDA announces new drug labeling for pharmacogenetic testing: is personalized medicine becoming a reality?
Vladutiu GD
Mol Genet Metab; 2008 Jan; 93(1):1-4. PubMed ID: 18054511
[No Abstract] [Full Text] [Related]
5. Tailoring warfarin induction doses to reflect individual and disease-specific factors.
Ageno W; Squizzato A; Dentali F; Crowther M
Am J Med; 2005 Feb; 118(2):143-4. PubMed ID: 15694898
[No Abstract] [Full Text] [Related]
6. Decreased INR response secondary to warfarin-flucloxacillin interaction.
Garg A; Mohammed M
Ann Pharmacother; 2009 Jul; 43(7):1374-5. PubMed ID: 19584391
[No Abstract] [Full Text] [Related]
7. [Application of warfarin pharmacogenetics].
Vasků A
Vnitr Lek; 2009 Jun; 55(6):541. PubMed ID: 19662883
[No Abstract] [Full Text] [Related]
8. Warfarin: an old drug but still interesting.
Johnson JA
Pharmacotherapy; 2008 Sep; 28(9):1081-3. PubMed ID: 18752378
[No Abstract] [Full Text] [Related]
9. The critical path of warfarin dosing: finding an optimal dosing strategy using pharmacogenetics.
Lesko LJ
Clin Pharmacol Ther; 2008 Sep; 84(3):301-3. PubMed ID: 18714317
[No Abstract] [Full Text] [Related]
10. PharmGKB and the International Warfarin Pharmacogenetics Consortium: the changing role for pharmacogenomic databases and single-drug pharmacogenetics.
Owen RP; Altman RB; Klein TE
Hum Mutat; 2008 Apr; 29(4):456-60. PubMed ID: 18330919
[TBL] [Abstract][Full Text] [Related]
11. ["Triple therapy" with warfarin, clopidogrel and acetylsalicylic acid. High risk treatment with unclear benefit].
Wallén H; Agren A; Nekludov M
Lakartidningen; 2007 Nov 28-Dec 4; 104(48):3640-2. PubMed ID: 18193674
[No Abstract] [Full Text] [Related]
12. Warfarin pharmacogenetics: an illustration of the importance of studies in minority populations.
Perera MA; Cavallari LH; Johnson JA
Clin Pharmacol Ther; 2014 Mar; 95(3):242-4. PubMed ID: 24548987
[TBL] [Abstract][Full Text] [Related]
13. Finding a liability-free space in which personalized medicine can bloom.
Evans BJ
Clin Pharmacol Ther; 2007 Oct; 82(4):461-5. PubMed ID: 17713468
[TBL] [Abstract][Full Text] [Related]
14. Warfarin pharmacogenomics: a big step forward for individualized medicine: enlightened dosing of warfarin.
Elias DJ; Topol EJ
Eur J Hum Genet; 2008 May; 16(5):532-4. PubMed ID: 18301451
[No Abstract] [Full Text] [Related]
15. [Personalized medicine: current status].
Tsujimoto G
Arerugi; 2004 Oct; 53(10):1062-5. PubMed ID: 15672724
[No Abstract] [Full Text] [Related]
16. State and federal legislation in personalized medicine.
Raich T; Irwin J
MLO Med Lab Obs; 2007 Aug; 39(8):48. PubMed ID: 17867420
[No Abstract] [Full Text] [Related]
17. What to do when warfarin therapy goes too far.
Prasad S; Wootten MR; Kulinski N; Chapman SA
J Fam Pract; 2009 Jul; 58(7):346-52. PubMed ID: 19607771
[TBL] [Abstract][Full Text] [Related]
18. [Individualized medicine between expectations and reality].
Hinneburg I
Med Monatsschr Pharm; 2011 Jun; 34(6):212-4. PubMed ID: 21812253
[No Abstract] [Full Text] [Related]
19. Personalized medicine: building the GPS to take us there.
Ratain MJ
Clin Pharmacol Ther; 2007 Mar; 81(3):321-2. PubMed ID: 17339859
[No Abstract] [Full Text] [Related]
20. Patient education about anticoagulant medication: is narrative evidence or statistical evidence more effective?
Mazor KM; Baril J; Dugan E; Spencer F; Burgwinkle P; Gurwitz JH
Patient Educ Couns; 2007 Dec; 69(1-3):145-57. PubMed ID: 17942268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
